How lawyers
paid for vaccine research - Andrew Wakefield's story proven false
This page
is material from the award-winning investigation by Brian Deer for The Sunday Times of London, the
UKs Channel 4 TV network and BMJ, the British
Medical Journal, which exposed vaccine
research fraudster Andrew Wakefield |
Investigation
summary
Among
Deer's key discoveries was that Wakefield
research had been funded through
lawyers suing drug firms over MMR.
But in February 2004, Wakefield and his
former Royal Free colleague Richard Horton, editor of the
Lancet, made formal public statements
claiming that the legal work was
"scientific" and "quite
separate" from the Lancet clinical
study. This story was was false, as these
letters, obtained by
Deer under the Freedom of Information
Act, and audio clips
from interviews by Deer below reveal
| |
|
(1)
23.05.97:
Wakefield asks hospital to bank
MMR money On 6
June 1996, Andrew Wakefield and
lawyer Richard
Barr asked what
was then the UK's Legal Aid Board
(now the Legal Services
Commission) for money to fund
"clinical and
scientific" tests on 10
children involved in a lawsuit
being prepared against MMR
manufacturers. They supplied the
LAB with a "proposed
protocol"
document, and another, much
longer protocol, virtually the
same as one submitted soon
after to the Royal Free's ethics
committee. After a contract with
Wakefield was awarded by the
board in August 1996, the money
came through as a disbursement
from Barr's law firm, Dawbarns,
to the Royal Free's medical
school.
|
But
the school's dean, Professor Arie
Zuckerman, questioned the
arrangement on ethical grounds. This
posed Wakefield, who, since February 1996
had been employed by the lawyer in a
joint attack on MMR, a problem. As the
first letter below reveals, he then asked
the hospital's management to bank it for
his use in a special trust which it
controlled.
ECRs,
mentioned above in paragraph 2, are
"extra-contractual referrals" -
now disbanded "internal market"
arrangements under which GP and medical
centre budgets paid for patient
admissions to hospitals (often very
profitably for the hospital). In short,
ECRs meant money.
Wakefield
refers to an account already being used
by the NHS hospital, and already holding
hospital money "to fund Ms
Rosalind Sim". In the light
of its ECR income, the hospital had
already agreed to pay Sim's salary from
its own funds more than seven months
before Wakefield's request to bank his
legal money. The account was Special
Trustees Account 106, established in
January 1994, which received cheques from
drug companies and other Wakefield
sponsors.
Wakefield
makes damningly explicit in his letter
that the legal money was provided
"for the express purpose of
performing the study outlined in the
enclosed protocol". This protocol describes
the clinical work published in the Lancet
in February 1998. Claims in 2004 by
Wakefield and Richard Horton of the
Lancet that the contract was for a
separate "scientific" study are
thus proven to be false. The MMR findings
in the Lancet were simply paid for by a
law firm - a position confirmed by
Richard Barr in interviews with Brian
Deer [listen
below].
Giving
evidence in 2008 before a fitness to
practice panel of the UK General Medical
Council, Wakefield astounded the panel by
denying the plain words on the page -
including the clear statement that the
Legal Aid Board paid for clinical
research, and also his use of the word
"recruited". Wakefield's
argument prompted astonished questioning
from the panel when he claimed that the
document was wrong because he had written
it to an accountant.
In
August 2009, Wakefield appeared on
Dateline NBC in the United States, where
he claimed that the children in the
Lancet study were: "Nothing to do
with research, nothing to do with class
actions, nothing to do with
vaccines." The material on this
page, plainly, say otherwise. The very
first letter explains that "the
study" was funded by the Legal Aid
Board, and was "to establish the
validity of the parents' claims of an
association with MMR".
(2)
30.06.97: Else agrees
"grant", using legal income
Given
the medical school's rejection of the
money from lawyers to pay for Wakefield's
MMR research findings, the hospital's
chief executive, Martin Else, agreed to
take it instead. He offered to pay it
back to Wakefield's research activities
as a "grant". All Mr Else, who
left the hospital in 2005, required - in
a letter headed "Special Trustees
Fund - MMR Research" - was what
amounted to a formal written waiver of
impropriety.
It's clear from this
letter that Else knew there was something
out-of-the-ordinary about him providing
"accounting functions" for
money from lawyers to fund research.
Moreover, as the MMR scare exploded in
February 1998, it seems that the chief
executive was in a position to know that
the allegation in the Lancet of a
possible MMR-autism connection, which
terrified parents and caused a slump in
immunisation rates (following a media
campaign orchestrated by his staff, with foreseen
consequences), had - by
Wakefield's own account in these letters
- been paid for through a law firm suing
MMR manufacturers.
| |
|
(3)
03.07.97:
Wakefield pledges 300 more
children for hospital Despite
his later denials of the plain
words of this correspondence,
Wakefield unmasks his claims of
2004 when he states in the first
sentence of the next letter that
the research paid for through
lawyers was "a clinical
study of children with autism and
intestinal inflammation".
He adds that
the research will determine
"any future actions"
against drug companies "if
and when our studies indicate
that is a valid strategy".
The letter also explicitly refers
to the Lancet paper.
|
The letter offers Else
a sweetener for any inconvenience: where
Wakefield speaks of "300 children
who merit investigation under this
protocol, most of these as ECRs (or
commissioned referrals for the
future)." The promise of a surge in
income from autistic children may have
been welcome to the hospital's
management, but as of July 1997 it's
clear that many of these children may
have been identified through the client
lists of Richard Barr, and from two
organisations run by MMR litigants:
Jackie Fletcher's organisation JABS, and
Rosemary Kessick's Allergy-Induced
Autism. Fletcher told Brian Deer in a
September 2003 telephone interview that
all 12 of the children in the Lancet
study "were investigated through the
JABS group". She was exaggerating
somewhat.
(4)
24.07.97: Hospital
confirms account 106 ready
In a
letter to the medical school - headed
"Dr A Wakefield: Legal Aid Board
Sponsored Research" - the hospital
identifies account 106 as the reference
for the transferred money.
And so the arrangement
was in place. According to these
documents, money which helped finance the
launch of the worldwide MMR scare was
paid from the Legal Aid Board to Barr's
firm Dawbarns. After the medical school's
rejection, payments from Barr were
transferred to the hospital's Special
Trustees, who then granted it back to
Wakefield's medical school research, set
out in the protocol.
Finally,
the Special Trustees' involvement was
acknowledged in the Lancet paper ["This
study was supported by the Special
Trustees of Royal Free Hampstead NHS
Trust"], but with the Legal
Aid Board not mentioned. Thus, cash that
might be regarded as contentious
[evidently the dean's view] was
laundered to Wakefield's benefit, with
the public left none the wiser. At a US
Congressional committee hearing later,
Wakefield was asked squarely by an
admirer: "Who funded your
study?" This was his
answer.
In
December 2006, Brian Deer reported in The Sunday
Times on more than £435,643
in fees, plus expenses, which the Legal
Services Commission says it paid to
Wakefield for his part in the lawsuit.
Both the contractual arrangement and the
payments had never been revealed before,
in any forum whatsoever.
Audio
clips: What they say
about Lancet research cash
MP3
AUDIO: Hear Professor
John Walker-Smith, head of the
Royal Free's department of paediatric
gastroenterology, who admitted the
children for the Lancet research, react
to the news in February 2004. He says he
had no idea about Andrew Wakefield's
contract.
MP3
AUDIO: Hear Richard Barr, the lawyer who
ran the MMR case, explain to Brian Deer
how he paid for the Lancet research and
couldn't understand why this wasn't
frankly acknowledged in the paper. Also
how he then had only one
"expert". February 2004.
MP3
AUDIO: Hear Richard
Horton, editor of the Lancet,
reading an email from Andrew Wakefield
trying to head off Brian Deer's
investigation, and telling Horton that
the Legal Aid Board "contributed in
no way to the funding of the
report". February 2004.
|